fda glp-1 shortage Ro launches supply tracker to help patients navigate shortages FDA restricts non-approved compounded GLP-1

If the aorta is ruptured, then blood does not flow to other areas like the legs, feet and brain, which can lead to lasting brain damage or death

Hyperparathyroidism in MEN2A Hyperparathyroidism is an uncommon manifestation of MEN2A (5% to 10%)

It is best advised to confirm the result with a healthcare professional and learn what can lead to a false positive pregnancy test

Patients should contact their healthcare provider if they experience severe or persistent side effects, signs of hypoglycaemia (particularly if taking insulin or sulfonylureas), symptoms of pancreatitis (severe abdominal pain), or if there is no improvement in blood glucose control after 6 months of treatment at the maximum tolerated dose

IQVIA Payer Control Library The Bottom Line The GLP-1 market sits at the intersection of clinical innovation and patient behavior, where real-world persistence often falls short of therapeutic potential